BI
₹29.34
-0.92(-3.04%)
BIOFILCHEM₹29.34-3.04%
49/100
0100 · strongest
moderate
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %BIOFILCHEM financial summary
For Mar 2026, Biofil Chemicals & Pharmaceuticals Limited reported revenue of ₹28 crore, which fell 15.0% from the previous year. Net profit was ₹3 crore, which grew 398.2% year on year, on an operating margin of 2%. Earnings per share came in at ₹1.71. Over the 5 years from Mar 2021 to Mar 2026, revenue changed at a compound annual rate of -4.5% and net profit at 17.6%. The highest operating margin in that period was 6% in Mar 2022. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹28 crore |
|---|---|
| Net profit | ₹3 crore |
| Operating margin | 2% |
| EPS | ₹1.71 |